Charles R. Kummeth - Jan 28, 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Jan 28, 2022
Transactions value $
$199,896
Form type
4
Date filed
2/1/2022, 03:35 PM
Previous filing
Sep 7, 2021
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $100K +938 +0.48% $106.59 198K Jan 28, 2022 Direct F1
transaction TECH Common Stock Options Exercise $99.9K +799 +0.4% $125.05 198K Jan 28, 2022 Direct F1
holding TECH Common Stock 100 Jan 28, 2022 By Step-Son
holding TECH Common Stock 100 Jan 28, 2022 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -938 -0.37% $0.00 256K Jan 28, 2022 Common Stock 938 $106.59 Direct F2
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -799 -0.41% $0.00 195K Jan 28, 2022 Common Stock 799 $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 100K Jan 28, 2022 Common Stock 100K $108.49 Direct F2
holding TECH Stock Options (Right to Buy) 90.3K Jan 28, 2022 Common Stock 90.3K $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 60.2K Jan 28, 2022 Common Stock 60.2K $177.32 Direct F3
holding TECH Restricted Stock Units 16.9K Jan 28, 2022 Common Stock 16.9K Direct F4, F5
holding TECH Stock Options (Right to Buy) 85.7K Jan 28, 2022 Common Stock 85.7K $190.41 Direct F5
holding TECH Stock Options (Right to Buy) 57.2K Jan 28, 2022 Common Stock 57.2K $190.41 Direct F6
holding TECH Restricted Stock Units 12.9K Jan 28, 2022 Common Stock 12.9K Direct F4, F7
holding TECH Stock Options (Right to Buy) 57.4K Jan 28, 2022 Common Stock 57.4K $267.87 Direct F7
holding TECH Stock Options (Right to Buy) 38.3K Jan 28, 2022 Common Stock 38.3K $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 16.7K Jan 28, 2022 Common Stock 16.7K $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 16.7K Jan 28, 2022 Common Stock 16.7K $267.87 Direct F10
holding TECH Restricted Stock Units 8.02K Jan 28, 2022 Common Stock 8.02K Direct F4, F11
holding TECH Stock Options (Right to Buy) 31.3K Jan 28, 2022 Common Stock 31.3K $481.82 Direct F11
holding TECH Stock Options (Right to Buy) 20.9K Jan 28, 2022 Common Stock 20.9K $481.82 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024.
F2 Fully exercisable.
F3 Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F5 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
F7 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F9 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F10 Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F11 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12 Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.